NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
23 hedge funds and large institutions have $1.81M invested in InVivo Therapeutics Holdings Corp in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$162K |
| 2 |
2
Renaissance Technologies
New York
|
$394K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$205K |
| 4 |
4
Morgan Stanley
New York
|
$38K |
| 5 |
5
Goldman Sachs
New York
|
$30K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$644K |
| 2 |
VF
2
Virtu Financial
New York
|
$33K |
| 3 |
3
Bank of New York Mellon
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
5
Millennium Management
New York
|
$10K |
